<DOC>
	<DOC>NCT01312350</DOC>
	<brief_summary>The investigators will examine whether 2-cycles of DFP chemotherapy before definitive concurrent chemoradiation therapy (CCRT) can improve progression-free survival in locally advanced (Stage III &amp; IVM0) hypopharyngeal and base of tongue carcinoma compared to definitive CCRT alone.</brief_summary>
	<brief_title>Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)</brief_title>
	<detailed_description />
	<mesh_term>Hypopharyngeal Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Histologically/cytologically proven stage III/IVM0 hypopharyngeal or base of tongue cancer One or more evaluable or measurable lesion No prior chemotherapy, radiation, or surgery ECOG 02 Distant metastasis Other malignancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>neoadjuvant chemotherapy</keyword>
	<keyword>definitive chemoradiation therapy</keyword>
	<keyword>head and neck cancer</keyword>
	<keyword>base of tongue</keyword>
	<keyword>Locally advanced</keyword>
</DOC>